2 assets in Alzheimer Disease 3

Therapeutic assets addressing Alzheimer Disease 3, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Lacosamide Alzheimer Disease 3	Xiangya Hospital of Central South University	P4	BB (65)
Aph-1105 Alzheimer Disease 3	Aphios	P2	CCC (53)